Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03970642 · ClinicalTrials.gov registry record · NA
Video Directly Observed Therapy (VDOT) to Improve Medication Adherence
A NA study, sponsored by UConn Health.
- Terminated
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT03970642: Clinical Trial NA study, sponsored by UConn Health.
NCT03970642 is a NA study that was terminated before completion, run by UConn Health. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03970642, a NA study, was terminated before completion, sponsored by UConn Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
Due to the lack of human resources, it is impossible to monitor patients' medication adherence objectively or in-person by observation like tuberculosis programs worldwide do. The feasibility and patient acceptance of the innovative video-based directly observed therapy (VDOT) approach for improving medication adherence among tuberculosis patients has been demonstrated through studies in the United States as well as internationally (7). Medication adherence among VDOT users has been found to be comparable to in-person directly observed treatment (91% vs 95%) among patients in New York (8). In this clinical research project, we will test the feasibility, acceptance and effectiveness of an innovative mobile-based behavioral intervention to improve medication adherence and depression symptoms among patients suffering from depression.
Primary Outcome
The change in medication adherence during the study period will be determined using the ASK-20 questionnaire. The ASK-20 questionnaire includes 20 questions, each with a likert response from 1 to 5 with 1 representing excellent and 5 representing poor medication adherence.
Interventions
- OTHER Video directly observed therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-05-27 |
| Est. Completion | 2020-04-15 |
| Phase | NA |
Why NCT03970642 stopped before completion
NCT03970642 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Video directly observed therapy is the first listed.
NCT03970642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03970642 about?
NCT03970642 is a clinical study titled "Video Directly Observed Therapy (VDOT) to Improve Medication Adherence". Due to the lack of human resources, it is impossible to monitor patients' medication adherence objectively or in-person by observation like tuberculosis programs worldwide do. The feasibility and patient acceptance of the innovative video-based directly observed therapy (VDOT) approach for improving...
What is the current status of trial NCT03970642?
This trial is currently terminated. It is a NA study. The enrollment target is 35 participants. The study started on 2019-05-27. Estimated completion is 2020-04-15.
What interventions are being tested in trial NCT03970642?
The interventions under investigation include: Video directly observed therapy (OTHER).
Who is sponsoring clinical trial NCT03970642?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03970642's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI